Literature DB >> 23279968

16th IHIW: international histocompatibility working group in hematopoietic cell transplantation.

E W Petersdorf1, M Malkki, K Hsu, P Bardy, A Cesbron, A Dickinson, V Dubois, K Fleischhauer, T Kawase, A Madrigal, Y Morishima, B Shaw, S Spellman, E Spierings, M Stern, J-M Tiercy, A Velardi, T Gooley.   

Abstract

The International Histocompatibility Working Group is a collaborative international effort to understand the HLA and non-HLA genetics of the transplantation barrier. The Working Group is comprised of experts in the fields of histocompatibility and immunogenetics, hematopoietic cell transplantation and outcomes research. Data for 25 855 unrelated donor transplants were submitted in support of research studies for the 16th International Histocompatibility Workshop. Active investigation is in progress in seven key areas: the impact of HLA matching, role of race and ethnicity, identification of permissible HLA mismatches, haplotype-associated determinants, minor histocompatibility antigens, immune response genes and KIR genetics. New hypotheses for the 16th workshop were developed for immunogenetic studies in cord blood and haploidentical-related donor transplantation.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23279968      PMCID: PMC3887040          DOI: 10.1111/iji.12022

Source DB:  PubMed          Journal:  Int J Immunogenet        ISSN: 1744-3121            Impact factor:   1.466


  13 in total

Review 1.  Evaluation of published single nucleotide polymorphisms associated with acute GVHD.

Authors:  Jason W Chien; Xinyi Cindy Zhang; Wenhong Fan; Hongwei Wang; Lue Ping Zhao; Paul J Martin; Barry E Storer; Michael Boeckh; Edus H Warren; John A Hansen
Journal:  Blood       Date:  2012-01-26       Impact factor: 22.113

2.  Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy.

Authors:  Vanderson Rocha; Stephen Spellman; Mei-Jie Zhang; Annalisa Ruggeri; Duncan Purtill; Colleen Brady; Lee Ann Baxter-Lowe; Etienne Baudoux; Paola Bergamaschi; Robert Chow; Brian Freed; Gesine Koegler; Joanne Kurtzberg; Jerome Larghero; Lucilla Lecchi; Arnon Nagler; Cristina Navarrette; Vinod Prasad; Fabienne Pouthier; Thomas Price; Voravit Ratanatharathorn; Jon J van Rood; Mary M Horowitz; Eliane Gluckman; Mary Eapen
Journal:  Biol Blood Marrow Transplant       Date:  2012-07-17       Impact factor: 5.742

3.  Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.

Authors:  Katharina Fleischhauer; Bronwen E Shaw; Theodore Gooley; Mari Malkki; Peter Bardy; Jean-Denis Bignon; Valérie Dubois; Mary M Horowitz; J Alejandro Madrigal; Yasuo Morishima; Machteld Oudshoorn; Olle Ringden; Stephen Spellman; Andrea Velardi; Elisabetta Zino; Effie W Petersdorf
Journal:  Lancet Oncol       Date:  2012-02-15       Impact factor: 41.316

4.  HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.

Authors:  Jeffrey M Venstrom; Gianfranco Pittari; Ted A Gooley; Joseph H Chewning; Stephen Spellman; Michael Haagenson; Meighan M Gallagher; Mari Malkki; Effie Petersdorf; Bo Dupont; Katharine C Hsu
Journal:  N Engl J Med       Date:  2012-08-30       Impact factor: 91.245

5.  Impact of HLA-DPB1 haplotypes on outcome of 10/10 matched unrelated hematopoietic stem cell donor transplants depends on MHC-linked microsatellite polymorphisms.

Authors:  Florence Bettens; Jakob Passweg; Urs Schanz; Yves Chalandon; Dominik Heim; Tayfun Güngör; Georg Stussi; Grazia Nicoloso; Helen Baldomero; Alois Gratwohl; Jean-Marie Tiercy
Journal:  Biol Blood Marrow Transplant       Date:  2011-10-01       Impact factor: 5.742

6.  Human leukocyte antigen DR15 is associated with reduced relapse rate and improved survival after human leukocyte antigen-identical sibling hematopoietic stem cell transplantation.

Authors:  Martin Stern; Jakob Passweg; Jean-Marie Tiercy; Alexander Genitsch; Sandrine Meyer-Monard; Dominik Heim; André Tichelli; Alois Gratwohl; Catherine Nissen-Druey
Journal:  Biol Blood Marrow Transplant       Date:  2006-11       Impact factor: 5.742

7.  KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.

Authors:  Katharine C Hsu; Ted Gooley; Mari Malkki; Clara Pinto-Agnello; Bo Dupont; Jean-Denis Bignon; Martin Bornhäuser; Frank Christiansen; Alois Gratwohl; Yasuo Morishima; Machteld Oudshoorn; Olle Ringden; Jon J van Rood; Effie Petersdorf
Journal:  Biol Blood Marrow Transplant       Date:  2006-08       Impact factor: 5.742

8.  Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation.

Authors:  Jeffrey M Venstrom; Ted A Gooley; Stephen Spellman; James Pring; Mari Malkki; Bo Dupont; Effie Petersdorf; Katharine C Hsu
Journal:  Blood       Date:  2010-02-01       Impact factor: 22.113

9.  HLA mismatches and hematopoietic cell transplantation: structural simulations assess the impact of changes in peptide binding specificity on transplant outcome.

Authors:  Chen Yanover; Effie W Petersdorf; Mari Malkki; Ted Gooley; Stephen Spellman; Andrea Velardi; Peter Bardy; Alejandro Madrigal; Jean-Denis Bignon; Philip Bradley
Journal:  Immunome Res       Date:  2011

10.  A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation.

Authors:  Elisabetta Zino; Guido Frumento; Sarah Marktel; Maria Pia Sormani; Francesca Ficara; Simona Di Terlizzi; Anna Maria Parodi; Ruhena Sergeant; Miryam Martinetti; Andrea Bontadini; Francesca Bonifazi; Daniela Lisini; Benedetta Mazzi; Silvano Rossini; Paolo Servida; Fabio Ciceri; Chiara Bonini; Edoardo Lanino; Giuseppe Bandini; Franco Locatelli; Jane Apperley; Andrea Bacigalupo; Giovanni Battista Ferrara; Claudio Bordignon; Katharina Fleischhauer
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

View more
  7 in total

1.  Biological significance of HLA locus matching in unrelated donor bone marrow transplantation.

Authors:  Yasuo Morishima; Koichi Kashiwase; Keitaro Matsuo; Fumihiro Azuma; Satoko Morishima; Makoto Onizuka; Toshio Yabe; Makoto Murata; Noriko Doki; Tetsuya Eto; Takehiko Mori; Koichi Miyamura; Hiroshi Sao; Tatsuo Ichinohe; Hiroo Saji; Shunichi Kato; Yoshiko Atsuta; Keisei Kawa; Yoshihisa Kodera; Takehiko Sasazuki
Journal:  Blood       Date:  2014-12-17       Impact factor: 22.113

2.  HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.

Authors:  Effie W Petersdorf; Theodore A Gooley; Mari Malkki; Andrea P Bacigalupo; Anne Cesbron; Ernette Du Toit; Gerhard Ehninger; Torstein Egeland; Gottfried F Fischer; Thibaut Gervais; Michael D Haagenson; Mary M Horowitz; Katharine Hsu; Pavel Jindra; Alejandro Madrigal; Machteld Oudshoorn; Olle Ringdén; Marlis L Schroeder; Stephen R Spellman; Jean-Marie Tiercy; Andrea Velardi; Campbell S Witt; Colm O'Huigin; Richard Apps; Mary Carrington
Journal:  Blood       Date:  2014-10-16       Impact factor: 22.113

3.  Graft-versus-host disease and survival after cord blood transplantation for acute leukemia: a comparison of Japanese versus White populations.

Authors:  Yachiyo Kuwatsuka; Yoshiko Atsuta; Mary M Horowitz; Jiro Inagaki; Junya Kanda; Koji Kato; Katsuyoshi Koh; Mei-Jie Zhang; Mary Eapen
Journal:  Biol Blood Marrow Transplant       Date:  2014-02-10       Impact factor: 5.742

4.  A Micropolymorphism Altering the Residue Triad 97/114/156 Determines the Relative Levels of Tapasin Independence and Distinct Peptide Profiles for HLA-A(*)24 Allotypes.

Authors:  Soumya Badrinath; Heike Kunze-Schumacher; Rainer Blasczyk; Trevor Huyton; Christina Bade-Doeding
Journal:  J Immunol Res       Date:  2014-12-04       Impact factor: 4.818

5.  Soluble HLA technology as a strategy to evaluate the impact of HLA mismatches.

Authors:  Heike Kunze-Schumacher; Rainer Blasczyk; Christina Bade-Doeding
Journal:  J Immunol Res       Date:  2014-09-01       Impact factor: 4.818

6.  HLA genotyping by next-generation sequencing of complementary DNA.

Authors:  Hidenobu Segawa; Yoji Kukita; Kikuya Kato
Journal:  BMC Genomics       Date:  2017-11-28       Impact factor: 3.969

7.  Sequence Variations Within HLA-G and HLA-F Genomic Segments at the Human Leukocyte Antigen Telomeric End Associated With Acute Graft-Versus-Host Disease in Unrelated Bone Marrow Transplantation.

Authors:  Shingo Suzuki; Satoko Morishima; Makoto Murata; Masafumi Tanaka; Atsuko Shigenari; Sayaka Ito; Uma Kanga; Jerzy K Kulski; Yasuo Morishima; Takashi Shiina
Journal:  Front Immunol       Date:  2022-07-21       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.